The present invention relates to a compound of the Formula (I)):
or pharmaceutically acceptable salt thereof, wherein the symbols are as defined in the specification; a pharmaceutical composition comprising the same, a method for treating or preventing viral infections, inflammation, dry eye, central nervous disorders, cardiovascular diseases, cancer, obesity, diabetes, muscular dystrophy, and hair loss.
Aldol-Type Chirons from Asymmetric Hydrogenations of Trisubstituted Alkenes
作者:Jian Zhao、Kevin Burgess
DOI:10.1021/ol900308w
日期:2009.5.21
Catalyst control dominates in the asymmetric hydrogenations of largely unfunctionalized trisubstituted alkenes formed from lactic acid and glyceraldehyde, affording syn- and ant aldol products of the type shown above.
FERRABOSCHI, PATRIZIA;GRISENTI, PARIDE;CASATI, ROSANGELA;FIECCHI, ALBERTO+, J. CHEM. SOC. PERKIN TRANS.,(1987) N 8, 1743-1748